Impact News +++ What Sparked AbCellera Biologics To Soar Over 9% After Hours (Benzinga) +++ ABCELLERA Aktie +3,13%

TRANSMEDICS Aktie

>TRANSMEDICS Aktienkurs

125.85 EUR +7.5% (TradegateBSX)

Ask: 125.85 EUR / 30 Stück

Bid: 124.1 EUR / 30 Stück

Tagesumsatz: 75 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

TRANSMEDICS Aktie über LYNX handeln

Intraday

1 Jahr

>TRANSMEDICS Performance

1 Woche: +4,0%

1 Monat: +2,0%

3 Monate: -4,4%

6 Monate: +16,6%

1 Jahr: +59,1%

laufendes Jahr: +12,3%

>TRANSMEDICS Aktie

Name:

TRANSMEDICS GROUP

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US89377M1099 / A2PH5P

Symbol/ Ticker:

8T8 (Frankfurt) / TMDX (NASDAQ)

Kürzel:

FRA:8T8, ETR:8T8, 8T8:GR, NASDAQ:TMDX

Index:

Webseite:

https://www.transmedics.c..

Profil:

TransMedics Group Inc. is a medical technology company focused on the commercialization of organ transplant therapy systems. The company has developed the Organ Care System (OCS), a transformative and..
>Volltext..

Marktkapitalisierung:

3908.37 Mio. EUR

Unternehmenswert:

3953.72 Mio. EUR

Umsatz:

481.04 Mio. EUR

EBITDA:

103.07 Mio. EUR

Nettogewinn:

77.94 Mio. EUR

Gewinn je Aktie:

2.3 EUR

Schulden:

441.11 Mio. EUR

Liquide Mittel:

395.95 Mio. EUR

Operativer Cashflow:

151.18 Mio. EUR

Bargeldquote:

5.85

Umsatzwachstum:

33.98%

Gewinnwachstum:

166.78%

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

Suchwörter:

TRANSMEDICS

Letzte Datenerhebung:

25.02.26

>TRANSMEDICS Kennzahlen

Aktien/ Unternehmen:

Aktien: 34.17 Mio. St.

Frei handelbar: 96.49%

Leerverk. Aktien: 23.09%

Rückkaufquote: -0.33%

Mitarbeiter: 728

Umsatz/Mitarb.: 0.52 Mio. EUR

Analysten:

Analystenrating: Buy

Kursziel: -1.89%

Bewertung:

KGV: 59.86

KGV lG: 57.08

KUV: 9.7

KBV: 14.25

PEG-Ratio: 0.33

EV/EBITDA: 38.36

Rentabilität:

Bruttomarge: 60.23%

Gewinnmarge: 16.2%

Operative Marge: 16.94%

Managementeffizenz:

Gesamtkaprendite: 10.6%

Eigenkaprendite: 32.48%

>TRANSMEDICS Peer Group

Gesundheit, Medizinprodukte & -technik/ Implantate/ Wundpflege

>TRANSMEDICS Chart & Kurs - NASDAQ

>TRANSMEDICS News

25.02.26 - 08:15	TransMedics outlines 20–25% 2026 revenue growth target while advancing OCS programs and European expansion (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

25.02.26 - 03:15	TransMedics (TMDX) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
	While the top- and bottom-line numbers for TransMedics (TMDX) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values....

25.02.26 - 03:15	TransMedics (TMDX) Beats Q4 Earnings and Revenue Estimates (Zacks)
	TransMedics (TMDX) delivered earnings and revenue surprises of +40.02% and +3.11%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?...

24.02.26 - 22:09	TransMedics Reports Fourth Quarter and Full Year 2025 Financial Results (PR Newswire)
	ANDOVER, Mass., Feb. 24, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today reported financial results for the quarter and......

24.02.26 - 22:09	TransMedics Group GAAP EPS of $2.62 beats by $2.26, revenue of $160.8M beats by $5.52M (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

23.02.26 - 16:45	Ahead of TransMedics (TMDX) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics (Zacks)
	Besides Wall Street's top-and-bottom-line estimates for TransMedics (TMDX), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2025....

20.02.26 - 22:06	TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
	ANDOVER, Mass., Feb. 20, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that on February 18, 2026,......

17.02.26 - 22:06	TransMedics to Present at Upcoming March Investor Conferences (PR Newswire)
	ANDOVER, Mass., Feb. 17, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced the company will be participating in......

16.02.26 - 18:15	TMDX Wins Full FDA IDE Approval for Next-Gen OCS ENHANCE Heart Trial (Zacks)
	TransMedics secures full FDA IDE approval for its OCS ENHANCE Heart trial, clearing a key hurdle and advancing its push to expand heart transplant use....

10.02.26 - 22:06	TransMedics to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 (PR Newswire)
	ANDOVER, Mass., Feb. 10, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today announced that it will release financial......

09.02.26 - 14:03	TransMedics Receives Full and Unconditional FDA IDE Approval for Next-Generation OCS Heart ENHANCE Trial (PR Newswire)
	ANDOVER, Mass., Feb. 9, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that the U.S. Food and Drug......

21.01.26 - 21:54	FDA-Zulassung für Konkurrenzprodukt belastet TransMedics-Aktie (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

14.01.26 - 18:15	Reasons to Retain TransMedics Stock in Your Portfolio for Now (Zacks)
	TMDX gains momentum as OCS technology, a robust pipeline and strong Q3 results fuel growth, though gross margin pressure tempers the outlook....

12.01.26 - 14:12	TransMedics Announces New Global Headquarters and Expansion at Assembly Innovation Park in Somerville, Massachusetts (PR Newswire)
	ANDOVER, Mass., Jan. 12, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a global leader in organ transplant technologies and services, today announced the signing of a long-term lease for its new global headquarters at Assembly Innovation Park in Somerville,......

09.01.26 - 16:45	3 MedTech Stocks That Crushed the S&P 500 Over the Past Year (Zacks)
	TransMedics, KORU Medical Systems and Cardinal Health beat the S&P 500 as execution, earnings visibility and company-specific catalysts drove gains....

08.01.26 - 17:12	Here′s How Much You Would Have Made Owning TransMedics Group Stock In The Last 5 Years (Benzinga)
	read more...

30.12.25 - 22:07	TransMedics to Participate in the 44th Annual J.P. Morgan Healthcare Conference (PR Newswire)
	ANDOVER, Mass., Dec. 30, 2025 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that members of the management team......

26.12.25 - 17:30	Here′s Why TransMedics (TMDX) is a Strong Growth Stock (Zacks)
	Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores....

24.12.25 - 22:06	TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
	ANDOVER, Mass., Dec. 24, 2025 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that on December 22, 2025,......

24.12.25 - 01:36	Here′s How Much $1000 Invested In TransMedics Group 5 Years Ago Would Be Worth Today (Benzinga)
	read more...

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Verstohlene Geschenke nimmt der Gottlose an, den Gang des Rechtes zu beugen. - Altes Testament: Spruch

Partner: >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram